Skip to content
10-Q

Quarterly Report

MYRIAD GENETICS INC MYGN

0000899923-25-000112

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 93.21M sh
Shares Diluted Q3 2025 · Sep 30, 2025 93.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 92.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 90.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 90.5M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$8.8M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$15.3M
Long Term Debt Q3 2025 · Sep 30, 2025 $119.5M
Long Term Debt Q3 2025 · Dec 31, 2024 $39.6M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $145.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $102.4M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $99.9M
Stockholders Equity Q3 2025 · Sep 30, 2025 $372.8M
Stockholders Equity Q3 2025 · Jun 30, 2025 $388.1M
Stockholders Equity Q3 2025 · Mar 31, 2025 $704.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 $701.1M
Stockholders Equity Q3 2025 · Sep 30, 2024 $731.7M
Stockholders Equity Q3 2025 · Jun 30, 2024 $740.5M
Stockholders Equity Q3 2025 · Mar 31, 2024 $760M
Stockholders Equity Q3 2025 · Dec 31, 2023 $783.2M
Current Liabilities Q3 2025 · Sep 30, 2025 $148M
Current Liabilities Q3 2025 · Dec 31, 2024 $164.1M
Total Liabilities Q3 2025 · Sep 30, 2025 $355.3M
Total Liabilities Q3 2025 · Dec 31, 2024 $326.5M
Current Assets Q3 2025 · Sep 30, 2025 $344.8M
Current Assets Q3 2025 · Dec 31, 2024 $298M
Total Assets Q3 2025 · Sep 30, 2025 $728.1M
Total Assets Q3 2025 · Dec 31, 2024 $1.03B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.29
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.24
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.94
Eps Basic Q3 2025 · Sep 30, 2025 −$0.29
Eps Basic Q3 2025 · Sep 30, 2025 −$3.88
Eps Basic Q3 2025 · Sep 30, 2024 −$0.24
Eps Basic Q3 2025 · Sep 30, 2024 −$0.94
Rd Expense Q3 2025 · Sep 30, 2025 $28.2M
Rd Expense Q3 2025 · Sep 30, 2025 $81.3M
Rd Expense Q3 2025 · Sep 30, 2024 $28.5M
Rd Expense Q3 2025 · Sep 30, 2024 $81.2M
Net Income Q3 2025 · Sep 30, 2025 −$27.4M
Net Income Q3 2025 · Sep 30, 2025 −$358M
Net Income Q3 2025 · Jun 30, 2025 −$330.5M
Net Income Q3 2025 · Mar 31, 2025 −$100K
Net Income Q3 2025 · Sep 30, 2024 −$22.1M
Net Income Q3 2025 · Sep 30, 2024 −$84.8M
Net Income Q3 2025 · Jun 30, 2024 −$36.7M
Net Income Q3 2025 · Mar 31, 2024 −$26M
Operating Income Q3 2025 · Sep 30, 2025 −$23.3M
Operating Income Q3 2025 · Sep 30, 2025 −$381.5M
Operating Income Q3 2025 · Sep 30, 2024 −$20M
Operating Income Q3 2025 · Sep 30, 2024 −$84.5M
Gross Profit Q3 2025 · Sep 30, 2025 $143.8M
Gross Profit Q3 2025 · Sep 30, 2025 $429.8M
Gross Profit Q3 2025 · Sep 30, 2024 $149.8M
Gross Profit Q3 2025 · Sep 30, 2024 $434.5M
Revenue Q3 2025 · Sep 30, 2025 $205.7M
Revenue Q3 2025 · Sep 30, 2025 $614.7M
Revenue Q3 2025 · Sep 30, 2024 $213.3M
Revenue Q3 2025 · Sep 30, 2024 $627M